Starling Oncology (STLNW) Property, Plant & Equipment (Net) Growth (1y) (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Property, Plant & Equipment (Net) Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.22 Bn | 1.16 Bn | -3.68% |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | 18.68% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 10.51% |
| 4 | Concentra Group Holdings Parent | 4.26 Bn | 4.10 Bn | 192.10 Mn | 2.62% |
| 5 | Privia Health | 2.57 Bn | 2.15 Bn | - | -67.11% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | -0.62% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | 110.56% |
| 8 | Surgery Partners | 1.84 Bn | 1.63 Bn | 622.10 Mn | -4.82% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.15 Bn | 41.94 Mn | 25.88% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | -2.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.50% |
| Mar 31, 2026 | -3.77% |
| Dec 31, 2025 | -10.13% |
| Sep 30, 2025 | -12.71% |
| Jun 30, 2025 | -11.27% |
| Mar 31, 2025 | 1.10% |
| Dec 31, 2024 | 9.23% |
| Sep 30, 2024 | 13.79% |
| Jun 30, 2024 | 13.55% |
| Mar 31, 2024 | 11.67% |
| Dec 31, 2023 | 27.33% |
| Sep 30, 2023 | 53.97% |
| Jun 30, 2023 | 79.12% |
| Mar 31, 2023 | 100.57% |
| Dec 31, 2022 | 103.89% |
| Dec 31, 2021 | 99.24% |